Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E38.87 EPS (ttm)3.30 Insider Own11.40% Shs Outstand1.04B Perf Week3.52%
Market Cap132.85B Forward P/E19.69 EPS next Y6.52 Insider Trans-2.37% Shs Float1.03B Perf Month4.55%
Income3.41B PEG3.60 EPS next Q1.35 Inst Own81.80% Short Float10.03% Perf Quarter17.59%
Sales24.56B P/S5.41 EPS this Y102.80% Inst Trans0.07% Short Ratio6.12 Perf Half Y21.34%
Book/sh9.72 P/B13.20 EPS next Y15.67% ROA7.40% Target Price122.00 Perf Year63.98%
Cash/sh7.81 P/C16.43 EPS next 5Y10.80% ROE26.40% 52W Range74.51 - 130.75 Perf YTD10.87%
Dividend2.58 P/FCF66.36 EPS past 5Y-5.30% ROI14.70% 52W High-1.87% Beta0.32
Dividend %2.01% Quick Ratio1.40 Sales past 5Y1.20% Gross Margin73.80% 52W Low72.19% ATR2.51
Employees38680 Current Ratio1.70 Sales Q/Q4.50% Oper. Margin15.20% RSI (14)63.43 Volatility1.59% 2.05%
OptionableYes Debt/Eq1.30 EPS Q/Q416.90% Profit Margin13.20% Rel Volume0.90 Prev Close128.31
ShortableYes LT Debt/Eq1.18 EarningsFeb 06 BMO Payout71.50% Avg Volume16.95M Price128.30
Recom2.40 SMA202.00% SMA505.71% SMA20018.76% Volume15,234,897 Change-0.01%
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-07-17Reiterated Barclays Overweight $85 → $90
Mar-20-17Reiterated UBS Neutral $70 → $85
Dec-16-16Upgrade Morgan Stanley Equal-Weight → Overweight
Mar-22-19 05:50PM  Eli Lilly (LLY) Stock Moves -0.01%: What You Should Know Zacks
06:01AM  Bull of the Day: DexCom (DXCM) Zacks
Mar-21-19 08:00PM  Better Buy: AbbVie vs. Eli Lilly Motley Fool
01:07PM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
09:54AM  Alkermes Focuses on Pipeline, Depends on Partners for Funds Zacks
09:46AM  Biogen shares tank nearly 30% after pulling key Alzheimers drug trial Yahoo Finance
07:12AM  9 High-Margin Stocks Seen Leading in Fed's New Dovish Era Investopedia
Mar-20-19 04:32PM  Eli Lilly Stock Is Up Because UBS Sees Reasons to Be Bullish Barrons.com
08:45AM  NCCN Announces Six Quality Improvement Projects in Gastric Cancer Care Approved for Collaboration with Lilly Oncology PR Newswire
Mar-16-19 01:52PM  The Numbers Say Eli Lilly Stock Has Still More Upside For Investors InvestorPlace
Mar-15-19 10:31AM  Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others Zacks
08:00AM  The Case Against Pfizer Stock and the Rest of the Industry InvestorPlace
Mar-14-19 05:01AM  Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades Investopedia
Mar-13-19 01:10PM  Lilly's Cyramza Successful in Phase III First-Line NSCLC Study Zacks
08:37AM  FDA medical adviser: 'Congress is owned by pharma' Yahoo Finance
08:00AM  Lilly Announces Final Results of Elanco Exchange Offer PR Newswire
Mar-12-19 05:50PM  Eli Lilly (LLY) Flat As Market Gains: What You Should Know Zacks
02:06PM  BioNtech hires banks for IPO worth up to $800 million - sources Reuters
01:29PM  Biontech stock offering could be worth as much as $800 million-sources Reuters
12:10PM  Eli Lilly Could Sustain Industry-Leading Growth, Says Bullish JPMorgan Benzinga
10:46AM  Eli Lillys Latest Move Proves the American Healthcare System Is Broken InvestorPlace
10:20AM  Allergan Announces FDA Acceptance of Migraine Candidate NDA Zacks
07:33AM  Here are the biggest analyst calls of the day: Tesla, Boeing, Coca-Cola, Monster Beverage, Eli Lilly CNBC
07:18AM  Lilly's combo therapy succeeds in late-stage lung cancer study Reuters
06:55AM  Lilly's combo treatment meets main goal in lung cancer late-stage study Reuters
06:45AM  Lilly's CYRAMZA® (ramucirumab) Phase 3 RELAY Trial Met Primary Endpoint, Significantly Improving Progression-Free Survival in First-Line Treatment of Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer PR Newswire
Mar-11-19 09:28PM  Dicerna Pharmaceuticals Inc (DRNA) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM  Elanco Animal Health Begins Trading After Eli Lilly Split Benzinga
12:59PM  Stocks - Dow Reverses Early Losses to End Higher as Tech Rallies Investing.com
10:06AM  The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's Zacks
06:45AM  Lilly Announces Preliminary Results of Elanco Exchange Offer PR Newswire
Mar-08-19 01:45PM  Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs Zacks
11:04AM  Celldex (CLDX) Q4 Loss Narrower than Expected, Sales Beat Zacks
09:30AM  Lilly (LLY) Up 7.5% Since Last Earnings Report: Can It Continue? Zacks
07:30AM  Lilly to Participate in Barclays Global Healthcare Conference PR Newswire
Mar-07-19 05:15PM  Lilly to Participate in Cowen Health Care Conference PR Newswire
08:48AM  Allergan's Depression Candidate Fails in Studies, Stock Down Zacks
06:45AM  Lilly Announces Final Exchange Ratio of 4.5121 for Elanco Exchange Offer PR Newswire
Mar-06-19 11:34AM  Lilly's Emgality Gets FDA Priority Review for Cluster Headache Zacks
09:25AM  FDA Approves Major Novel Depression Drug For First Time In 3 Decades Benzinga
08:50AM  J&J's (JNJ) Nasal Spray Spravato Gets FDA Nod for Depression Zacks
08:16AM  3 Big Pharmas Trying to Pop the Rebate Bubble Motley Fool
Mar-05-19 06:29PM  Eli Lilly to offer half-price version of insulin amid Trumps pressure to lower drug prices Fox Business Videos
09:00AM  Lilly to Bring Half-Priced Version of Popular Humalog Insulin Zacks
07:11AM  Eli Lilly will offer a half-off version of its popular insulin drug Humalog MarketWatch
06:45AM  Lilly Receives FDA Priority Review Designation for Emgality® (galcanezumab-gnlm) Injection for the Preventive Treatment of Episodic Cluster Headache in Adults PR Newswire
Mar-04-19 08:54PM  Drugmaker Eli Lilly cutting price of popular insulin Humalog CBS News Videos
02:32PM  Lilly to sell cheaper version of top-selling insulin Humalog Associated Press
01:42PM  Eli Lilly seeks to quell drug price anger with cheaper insulin Reuters
12:50PM  Eli Lilly Is Cutting the Price of a Key Drug By 50% Barrons.com
12:33PM  Cheaper Insulin Is a Big Victory for Patients Bloomberg
12:22PM  Eli Lilly Stock Drops After Launching Cheaper Version of Top-Selling Insulin TheStreet.com
10:26AM  Eli Lilly seeks to quell drug price anger with cheaper insulin Reuters
07:49AM  Stocks making the biggest moves premarket: Tesla, AT&T, Eli Lilly & more CNBC
07:26AM  [$$] Lilly to launch generic version of insulin at steep discount Financial Times
06:54AM  Eli Lilly to make generic insulin available at half of Humalog's current price MarketWatch
06:40AM  Lilly to introduce lower-priced insulin injection Reuters
06:30AM  Lilly to Introduce Lower-Priced Insulin PR Newswire
Mar-01-19 06:46PM  Market high stocks: 6 trades CNBC Videos
02:18PM  Radius (RDUS) Posts Narrower Q4 Loss on Robust Tymlos Sales Zacks
09:00AM  Nektar Therapeutics (NKTR) Q4 2018 Earnings Conference Call Transcript Motley Fool
08:50AM  The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis Benzinga
07:37AM  3 Big Stock Charts for Friday: Eli Lilly, Centene and LKQ Corporation InvestorPlace
06:45AM  Lilly to Present Data Demonstrating Continued Scientific Advancements in Broad Dermatology Portfolio at AAD Annual Meeting PR Newswire
Feb-28-19 06:44PM  Cramer: I'm kicking myself for not recommending these stocks CNBC Videos
06:21PM  Cramer: I'm kicking myself for not recommending these stocks CNBC
04:13PM  Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates Zacks
03:53PM  5 Pharmaceutical Stocks With Big Moats and Bridges Kiplinger
02:44PM  Woburn's Abpro strengthens Chinese ties with immuno-oncology deal American City Business Journals
02:28PM  Drug Price Debate: is Legislation Necessary? Yahoo Finance Video
10:16AM  United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates Zacks
Feb-26-19 02:40PM  Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line Zacks
11:51AM  5 Companies Hit 52-Week Highs GuruFocus.com
07:16AM  Better Buy: GlaxoSmithKline vs. Eli Lilly Motley Fool
Feb-25-19 10:03AM  The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft Zacks
08:17AM  Better Buy: Eli Lilly vs. Johnson & Johnson Motley Fool
Feb-24-19 10:46AM  Biogen, BioMarin, Lilly and Bristol-Myers Could Be in Crosshairs of Acquirers GuruFocus.com
Feb-22-19 05:08PM  Merck to Buy Immunotherapy Developer Immune Design for $300M Zacks
04:38PM  U.S. Senators launch bipartisan probe into rising insulin prices Reuters
04:03PM  U.S. Senators launch bipartisan investigation into rising insulin prices Reuters
10:45AM  Is Eli Lilly and Companys (NYSE:LLY) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
09:04AM  Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates Zacks
07:41AM  Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review Zacks
07:30AM  New Research Coverage Highlights FedEx, Honeywell International, Nielsen Holdings Plc, Changyou, J.B. Hunt Transport Services, and Eli Lilly Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Feb-21-19 09:39PM  What Pharma Investors Need to Know About Pfizer's Latest Disaster Motley Fool
10:08AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Feb-20-19 04:26PM  Better Buy: Pfizer vs. Eli Lilly Motley Fool
10:13AM  Eli Lilly and Company -- Moody's assigns A2 rating to Eli Lilly's notes; stable outlook Moody's
09:08AM  Allergan Responds to Investor's Call for CEO/Chair Role Split Zacks
08:42AM  Pfizer & Lilly's Pain Candidate Succeeds in Back Pain Study Zacks
Feb-19-19 11:48AM  Eli Lilly and Co (LLY) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
09:14AM  Bayer Obtains Full Rights to Vitrakvi From Lilly's Loxo Zacks
09:02AM  Merck's (MRK) Stock Up Almost 50% in a Year: Here's Why Zacks
07:22AM  Pfizer-Lilly drug shown to help reduce back pain in late-stage trial Reuters
06:56AM  Higher dose of Pfizer-Lilly drug helps reduce back pain in study Reuters
06:45AM  Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain PR Newswire
Feb-15-19 04:21PM  Elanco Animal Health Incorporated -- Moody's announces completion of a periodic review of ratings of Elanco Animal Health Incorporated Moody's
02:56PM  Primecap Management Trims Eli Lilly Position GuruFocus.com
02:49PM  Hagens Berman: Judge Denies Insulin Makers Motion to Dismiss Class-Action Lawsuit Regarding Skyrocketing Insulin Prices Business Wire
11:43AM  Bayer gains full Vitrakvi rights from Eli Lilly's Loxo Reuters
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as migraine prevention. In addition, it offers immunology products for the treatment of adults with rheumatoid arthritis, as well as for the treatment of plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia, and acute coronary syndrome. Further, the company provides animal health products, such as cattle feed additives; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and enteric diseases in swine and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; Dicerna Pharmaceuticals; and AC Immune SA. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zakrowski Donald AChief Accounting OfficerMar 22Sale128.501,000128,5004,595Mar 22 03:16 PM
Fry Stephen FSVP, HR & DiversityMar 12Sale123.1614,8471,828,557109,663Mar 13 12:47 PM
LILLY ENDOWMENT INC10% OwnerMar 01Sale128.43210,00026,971,215117,015,304Mar 04 02:13 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale127.011,000127,0105,595Mar 05 03:51 PM
LILLY ENDOWMENT INC10% OwnerFeb 28Sale126.73200,00025,345,017117,225,304Mar 01 01:25 PM
LILLY ENDOWMENT INC10% OwnerFeb 22Sale124.19195,00024,217,635117,425,304Feb 25 04:06 PM
LILLY ENDOWMENT INC10% OwnerFeb 19Sale122.48205,00025,108,513117,620,304Feb 20 01:35 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048082Feb 20 03:52 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 15Sale121.0025,0003,025,000132,962Feb 20 03:37 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.003,221054,175Feb 06 08:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.009,722050,946Feb 05 07:09 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0012,2220131,708Feb 05 07:04 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0012,7780102,548Feb 05 06:59 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.008,8890109,100Feb 05 06:55 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0012,2220136,756Feb 05 06:49 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.003,333020,901Feb 05 06:43 PM
LILLY ENDOWMENT INC10% OwnerJan 17Sale118.33136,57716,161,281117,825,304Jan 18 01:14 PM
LILLY ENDOWMENT INC10% OwnerJan 16Sale117.871,657195,315117,961,881Jan 17 01:15 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale117.7451,7666,095,136117,963,538Jan 16 02:36 PM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 10Sale112.9225,0002,822,95950,954Dec 12 03:15 PM
LILLY ENDOWMENT INC10% OwnerDec 04Sale119.0015,5001,844,536118,015,304Dec 06 03:43 PM
White Anne E.SVP & Pres-Lilly OncologyDec 02Option Exercise0.007,500017,103Dec 04 03:14 PM
LILLY ENDOWMENT INC10% OwnerNov 29Sale117.42185,00021,722,429118,030,804Nov 30 11:52 AM
LILLY ENDOWMENT INC10% OwnerNov 28Sale115.57190,00021,957,939118,215,804Nov 29 10:55 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.31195,00022,485,572118,405,804Nov 20 02:40 PM
LILLY ENDOWMENT INC10% OwnerNov 16Sale113.74200,00022,747,000118,600,804Nov 19 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 13Sale113.412,460278,979118,800,804Nov 14 10:44 AM
LILLY ENDOWMENT INC10% OwnerNov 12Sale113.48202,54022,984,877118,803,264Nov 13 10:51 AM
LILLY ELI & CO10% OwnerNov 06Sale14.00700,0009,800,0003,148,647Nov 08 11:34 AM
Norton JohnaSenior VP, Global QualityNov 03Option Exercise0.003,133019,225Nov 06 01:25 PM
LILLY ENDOWMENT INC10% OwnerOct 17Sale113.25174,69619,783,623119,005,804Oct 18 02:26 PM
LILLY ENDOWMENT INC10% OwnerOct 09Sale115.9110,6721,237,013119,180,500Oct 10 01:17 PM
LILLY ENDOWMENT INC10% OwnerOct 08Sale115.9114,6321,696,039119,191,172Oct 09 01:14 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale112.67116,03813,073,950119,205,804Oct 05 02:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lOct 04Sale114.647,000802,48045,224Oct 05 02:08 PM
LILLY ENDOWMENT INC10% OwnerOct 03Sale109.0178,9628,607,253119,321,842Oct 04 02:29 PM
LILLY ENDOWMENT INC10% OwnerSep 28Sale107.31107,55311,541,082119,400,804Oct 01 11:53 AM
LILLY ENDOWMENT INC10% OwnerSep 27Sale107.0092,4479,891,644119,508,357Sep 28 10:36 AM
LILLY ENDOWMENT INC10% OwnerSep 26Sale106.63134,41014,332,373119,600,804Sep 27 12:26 PM
LILLY ENDOWMENT INC10% OwnerSep 25Sale106.4155,5905,915,165119,735,214Sep 26 01:49 PM
LILLY ELI & CO10% OwnerSep 24Sale16.362,02733,1623,848,647Sep 26 02:50 PM
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM
LILLY ENDOWMENT INC10% OwnerJul 06Sale87.44180,00015,738,300121,700,804Jul 09 10:45 AM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39402,394Jul 09 11:58 AM
LILLY ENDOWMENT INC10% OwnerJul 05Sale86.62170,00014,725,740121,880,804Jul 06 11:13 AM
LILLY ENDOWMENT INC10% OwnerJun 15Sale86.65180,00015,597,720122,050,804Jun 18 12:39 PM
Skovronsky DanielSVP, CSO, and Pres. LRLJun 14Buy86.2210,000862,20055,199Jun 14 04:08 PM
LILLY ENDOWMENT INC10% OwnerJun 14Sale86.31107,6989,295,414122,230,804Jun 15 11:00 AM
LILLY ENDOWMENT INC10% OwnerJun 13Sale86.2711,104957,953122,338,502Jun 14 11:58 AM
LILLY ENDOWMENT INC10% OwnerJun 11Sale86.3851,1984,422,637122,349,606Jun 12 02:46 PM
LILLY ENDOWMENT INC10% OwnerJun 04Sale85.13135,47811,532,565122,400,804Jun 05 11:20 AM
LILLY ENDOWMENT INC10% OwnerJun 01Sale85.3139,5223,371,661122,536,282Jun 04 02:25 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 31Sale85.0025,0002,125,000124,534Jun 01 04:22 PM
LILLY ENDOWMENT INC10% OwnerMay 30Sale83.85180,00015,092,640122,575,804May 31 01:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 29Sale82.108,426691,7750May 31 01:05 PM
LILLY ENDOWMENT INC10% OwnerMay 11Sale81.97140,00011,475,940122,755,804May 14 02:29 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 03Sale78.509,027708,620135,458May 03 04:34 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 01Option Exercise0.0020,0000153,201May 03 04:34 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:29 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 01Option Exercise0.0020,0000158,468May 03 04:26 PM
LILLY ENDOWMENT INC10% OwnerApr 25Sale80.85180,00014,553,614122,895,804Apr 26 12:38 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 16Sale80.0817,3791,391,71028,273Apr 17 03:29 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 13Sale80.145,165413,92345,652Apr 17 03:29 PM